KraneShares KWEB Launches UCITS Options on Eurex to Enhance Risk Management Flexibility for European China Internet Sector Investors OPRT Oportun beats Q4 2025 EPS estimates by 103 percent shares gain 191 percent in todays session Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia